From Mayo Clinic – Some medical discoveries truly stand the test of time. The case of a dedicated Mayo Clinic chemist is a prime example….
Graves’ disease is caused by a generalized overactivity of the entire thyroid gland (hyperthyroidism). It is named for Robert Graves, an Irish physician, who described this form of hyperthyroidism about 150 years ago.
Graves’ Disease FAQs
The majority of symptoms of Graves’ disease are caused by the excessive production of thyroid hormones by the thyroid (see Hyperthyroidism brochure).
Graves’ disease is the only kind of hyperthyroidism that can be associated with inflammation of the eyes, swelling of the tissues around the eyes and bulging of the eyes (called Graves’ ophthalmopathy). Although many patients with Graves’ disease have redness and irritation of the eyes at some time, less than five percent ever develop enough inflammation of the eye tissues to cause serious or permanent trouble. Patients who have more than very mild eye symptoms do require an evaluation with an eye doctor (an ophthalmologist) as well as their endocrinologist.
Eye symptoms most often begin about six months before or after the diagnosis of Graves’ disease has been made. Seldom do eye problems occur long after the disease has been treated. In some patients with eye symptoms, hyperthyroidism never develops and, rarely, patients may be hypothyroid. The severity of the eye symptoms is not related to the severity of the hyperthyroidism. Early signs of trouble might be red or inflamed eyes, a bulging of the eyes due to inflammation of the tissues behind the eyeball or double vision. Diminished vision or double vision are rare problems that usually occur later if at all. We do not know why, but problems with the eyes occur much more often and are more severe in people with Graves’ disease who smoke cigarettes.
Rarely, patients with Graves’ disease develop a lumpy reddish thickening of the skin in front of the shins known as pretibial myxedema. This skin condition is usually painless and relatively mild, but can be painful. Like the eye trouble of Graves’ disease, the skin problem does not necessarily begin precisely when the hyperthyroidism starts. Its severity is not related to the level of thyroid hormone.
Graves’ disease is triggered by some process in the body’s immune system, which normally protects us from foreign invaders such as bacteria and viruses. The immune system destroys foreign invaders with substances called antibodies produced by blood cells known as lymphocytes. Some people inherit an immune system that can cause problems. Their lymphocytes make antibodies against their own tissues that stimulate or damage them. In Graves’ disease, antibodies bind to the surface of thyroid cells and stimulate those cells to overproduce thyroid hormones. This results in an overactive thyroid.
These same antibodies may also be involved in the eye changes seen in Graves’ ophthalmopathy, since the receptors on the thyroid may also be found on the surface of cells behind the eye. Physicians have long suspected that severe emotional stress, such as the death of a loved one, can set off Graves’ disease in some patients. Dr. Graves himself commented on stressful events in his patients’ lives that came several months before the development of hyperthyroidism. However, most patients who develop Graves’ disease report no particular recent stress in their lives.
The diagnosis of hyperthyroidism is made on the basis of your symptoms and findings during a physical exam and it is confirmed by laboratory tests that measure the amount of thyroid hormone (thyroxine, or T4, and triiodothyronine, or T3) and thyroid-stimulating hormone (TSH) in your blood (see the Hyperthyroidism brochure). Sometimes your doctor may want you to have a radioactive image, or scan, of the thyroid to see whether the entire thyroid gland is overactive. Your doctor may also wish to do a blood test to confirm the presence of thyroid-stimulating antibodies (TSI or TRAb) that cause Graves’ disease, but this test is not usually necessary.
Clues that your hyperthyroidism is caused by Graves’ disease are the presence of Graves’ eye disease (see above), an enlarged thyroid and a history of other family members with thyroid or autoimmune problems. Some relatives may have had hyperthyroidism or an underactive thyroid; others may have other autoimmune diseases including premature graying of the hair (beginning in their 20′s). Similarly, there may be a history of related immune problems in the family, including juvenile diabetes, pernicious anemia (due to lack of vitamin B12) or painless white patches on the skin known as vitiligo.
The treatment of hyperthyroidism is described in detail in the Hyperthyroidism brochure. Treatment includes antithyroid drugs (generally methimazole [Tapazole®], although propylthiouracil [PTU] may be used in rare instances), radioactive iodine and surgery. Although each treatment has its advantages and disadvantages, most patients will find one that is just right for them. Hyperthyroidism due to Graves’ disease is, in general, often easily controlled and safely treated and treatment is almost always successful.
No matter how your hyperthyroidism is controlled, you will probably eventually develop hypothyroidism (underactive thyroid). Hypothyroidism will occur sooner if your thyroid has been treated by radioactive iodine or removed in an operation. Even if you are treated with antithyroid drugs alone, hypothyroidism still can occur.
Because of this natural tendency to progress toward hypothyroidism sometime after you have been hyperthyroid, every patient who has ever had hyperthyroidism due to Graves’ disease should have blood tests at least once a year to measure thyroid function. When hypothyroidism occurs, a thyroid hormone tablet taken once a day can treat it simply and safely (see the Hypothyroidism brochure).
Because Graves’ disease is related to a genetic predisposition, examinations of the members of your family may reveal other individuals with thyroid problems.
More Information About Graves’ Disease
October 28, 2014 — A unique mouse model of Graves’ disease, an autoimmune disorder that causes hyperthyroidism, and new research findings that may help improve…
October 28, 2014 — New research leading to a better understanding of thyroid cell development, the safe use of medication to treat hyperthyroidism in pregnant…
Falls Church, Virginia. Sept. 19, 2012 – The American Thyroid Association (ATA) today announced it will honor Sandra McLachlan, PhD, of Cedars-Sinai Medical Center in…
New Rochelle, NY, June 10, 2011—New clinical guidelines developed by an expert panel that include 100 evidence-based recommendations for optimal care of patients with hyperthyroidism…